Sigachi Industries ended Q4 FY26 with revenue of ₹121.9 Cr, up 4% quarter-on-quarter but down 4.9% year-on-year.

Profit after tax (PAT) significantly improved to ₹7.6 Cr from a previous quarter's minor loss, though it was down 53% year-on-year.

For the full FY26, the company reported a loss of ₹82.8 Cr, primarily due to exceptional items.

Microcrystalline Cellulose (MCC) remains the primary revenue contributor, accounting for 88%. The company is fast-tracking its Dahej-2 facility expansion, aiming to boost total MCC capacity to 30,000 MTPA by Q4 FY27. Its new API R&D Centre in Hyderabad is now fully operational, focusing on developing higher-margin Active Pharmaceutical Ingredients.

Management expresses confidence in recovering margins and accelerating revenue growth in FY27. They project FY27 revenue targets between ₹650-675 Cr and an 18-20% EBITDA margin, anticipating stable global excipient demand and increased contributions from the API portfolio.

Capacity utilization is expected to exceed 65% post-expansion.